RA TV: Aduhelm & Patient-Centered Healthcare Reforms
RA TV
Scientific members of the RA Capital team lead periodic, public, interactive, webinar-style discussions on Zoom. Learn more here.
August 4, 2021
Heidi Wagner, Gunnar Esiason, and Peter Rubin of No Patient Left Behind join Peter Kolchinsky for a discussion of Biogen’s Aduhelm approval and a preview of federal actions on healthcare reform.
Panel:
Peter Rubin - Executive Director, NPLB
With more than 20 years of health policy, strategic advocacy, and public affairs experience, Peter has held senior-level positions spanning public and private sector payers, innovators, and regulators.
Gunnar Esiason - Board Member, NPLB
Gunnar Esiason is a rare disease patient leader, whose recovery from near end-stage cystic fibrosis thanks to a pharmaceutical breakthrough has motivated his desire to see cures delivered to the millions living with unmet medical needs.
Heidi Wagner - Board Member, NPLB
Heidi is a policy expert with experience on Capitol Hill and multiple international boards. As SVP of Global Government Affairs for Alexion, she helped craft and pass the Biologics Price Competition and Innovation Act as part of the ACA.
Join the RA TV crew live on Zoom every month by registering here or watch past episodes of RA TV on the RA Capital website.
—
RA Capital is a registered investment adviser. This material is not intended, and should not be construed as, investment advice or recommendation to invest in any security. Likewise, this material is not intended as a solicitation to invest in any RA Capital product or service.